Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)

T/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS) is an uncommon and aggressive leukemia without well-established treatment guidelines, particularly when relapsed. Venetoclax plus a hypomethylating agent offers a promising option in this situation since studies support its...

Descripción completa

Detalles Bibliográficos
Autores principales: Klocke, Heather, Dong, Zhao Ming, O'Brien, Craig, Burwick, Nicholas, Richard, Robert E., Wu, Daniel Y., Chauncey, Thomas R., Graf, Solomon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569429/
https://www.ncbi.nlm.nih.gov/pubmed/33101740
http://dx.doi.org/10.1155/2020/8811673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569429/
https://www.ncbi.nlm.nih.gov/pubmed/33101740
http://dx.doi.org/10.1155/2020/8811673

Ejemplares similares